Literature DB >> 7594462

Expression of ecto-adenosine deaminase and CD26 in human T cells triggered by the TCR-CD3 complex. Possible role of adenosine deaminase as costimulatory molecule.

M Martín1, J Huguet, J J Centelles, R Franco.   

Abstract

The expression of surface adenosine deaminase (ADA) and CD26 in activated human T cells was studied by flow cytometry. PBLs and CD3+ or CD4+ cells, when subjected to a variety of stimuli (anti-CD3 Abs plus IL-2 or phorbol esters), presented two structurally different cell populations, which differed in size and cellular complexity (populations B1 and B2). In PBLs triggered by an anti-CD3 mAb there was no significant increase of expression of either surface ADA or CD26 in cells of population B1, whose structure is similar to that of nonstimulated cells. In contrast, there was a significant increase in the percentage of expression of ADA and CD26 in the population B2, which corresponds to structurally more complex and larger cells. In the case of activation via TCR-CD3 but in the presence of IL-2 or via phorbol esters, the increase was found in cells from both populations, but B2 cells always showed a higher percentage of expression than B1 cells. The results of increased expression of surface ADA and CD26 were similar in whole T cells or in purer preparations such as CD3+ or CD4+ lymphocytes. Polyclonal Abs against ADA were not able to induce an activation response in T cells even when cross-linked by a secondary Ab. Interestingly, these Abs produced anergy in CD4+ cells subjected to an anti-CD3 stimulus. In contrast, addition of ADA produced an enzyme-independent synergism in the response through the TCR-CD3 complex. In T cells, ADA and CD26 colocalized on the surface of T cells; thus, the effect of exogenous ADA seems to be mediated by CD26 molecules that are not interacting with endogenous ADA (spare CD26 molecules). The presence of spare CD26 molecules on the surface of CD4+ cells was demonstrated by flow cytometry in the presence of exogenous ADA and also by confocal microscopy. The set of results strongly indicates that ADA binding to CD26 produces a costimulatory response in T cell activation events.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7594462

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  36 in total

1.  Glucagon-like peptide-1 receptor signalling reduces microvascular thrombosis, nitro-oxidative stress and platelet activation in endotoxaemic mice.

Authors:  Sebastian Steven; Kerstin Jurk; Maximilian Kopp; Swenja Kröller-Schön; Yuliya Mikhed; Kathrin Schwierczek; Siyer Roohani; Fatemeh Kashani; Matthias Oelze; Thomas Klein; Sergey Tokalov; Sven Danckwardt; Susanne Strand; Philip Wenzel; Thomas Münzel; Andreas Daiber
Journal:  Br J Pharmacol       Date:  2016-08-21       Impact factor: 8.739

2.  Long-term dipeptidyl-peptidase 4 inhibition reduces atherosclerosis and inflammation via effects on monocyte recruitment and chemotaxis.

Authors:  Zubair Shah; Thomas Kampfrath; Jeffrey A Deiuliis; Jixin Zhong; Colleen Pineda; Zhekang Ying; Xiaohua Xu; Bo Lu; Susan Moffatt-Bruce; Rekha Durairaj; Qinghua Sun; Georgeta Mihai; Andrei Maiseyeu; Sanjay Rajagopalan
Journal:  Circulation       Date:  2011-10-17       Impact factor: 29.690

Review 3.  Purinergic regulation of the immune system.

Authors:  Caglar Cekic; Joel Linden
Journal:  Nat Rev Immunol       Date:  2016-03       Impact factor: 53.106

4.  Cutting Edge: Adenosine A2a Receptor Signals Inhibit Germinal Center T Follicular Helper Cell Differentiation during the Primary Response to Vaccination.

Authors:  Shirdi E Schmiel; Jessica A Yang; Marc K Jenkins; Daniel L Mueller
Journal:  J Immunol       Date:  2016-12-16       Impact factor: 5.422

Review 5.  Receptor-receptor interactions involving adenosine A1 or dopamine D1 receptors and accessory proteins.

Authors:  R Franco; C Lluis; E I Canela; J Mallol; L Agnati; V Casadó; F Ciruela; S Ferré; K Fuxe
Journal:  J Neural Transm (Vienna)       Date:  2006-10-06       Impact factor: 3.575

6.  Adenosine deaminase modulation of telomerase activity and replicative senescence in human CD8 T lymphocytes.

Authors:  Stanley T Parish; Sarah Kim; Rekha K Sekhon; Jennifer E Wu; Yukako Kawakatsu; Rita B Effros
Journal:  J Immunol       Date:  2010-02-10       Impact factor: 5.422

7.  Human ADA2 belongs to a new family of growth factors with adenosine deaminase activity.

Authors:  Andrey V Zavialov; Ake Engström
Journal:  Biochem J       Date:  2005-10-01       Impact factor: 3.857

8.  Purification and characterization of intestinal adenosine deaminase from mice.

Authors:  L S Singh; R Sharma
Journal:  Mol Cell Biochem       Date:  2000-01       Impact factor: 3.396

9.  Immunological dysfunction in HIV-1-infected individuals caused by impairment of adenosine deaminase-induced costimulation of T-cell activation.

Authors:  José M Martinez-Navio; Núria Climent; Rodrigo Pacheco; Felipe Garcia; Montserrat Plana; Meritxell Nomdedeu; Harold Oliva; Cristina Rovira; Laia Miralles; José M Gatell; Teresa Gallart; Josefa Mallol; Carme Lluis; Rafael Franco
Journal:  Immunology       Date:  2009-11       Impact factor: 7.397

10.  Genetic ablation or pharmacological blockade of dipeptidyl peptidase IV does not impact T cell-dependent immune responses.

Authors:  Kalpit A Vora; Gene Porter; Roche Peng; Yan Cui; Kellyann Pryor; George Eiermann; Dennis M Zaller
Journal:  BMC Immunol       Date:  2009-04-09       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.